Evaluating the impact of influenza vaccination and certain medications on COVID-19 outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess whether patients admitted to the Hospital de Terrassa who have received the influenza vaccine or are on treatments such as ACE inhibitors, ARBs, antihistamines, or amantadine show improved outcomes in their COVID-19 infection. The study will analyze hospital admissions, treatment histories, lengths of stay, ICU needs, and survival rates. By comparing these factors, the researchers hope to determine if these interventions can enhance patient recovery from COVID-19.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Hospital Admissions at the Hospital of Terrassa from March 1, 2020 for any cause.

Exclusion Criteria:

* None.
* For comparison of percentage of Influenza vaccination, ACEI and ARB vs general population, patients from outside the reference area of the Terrassa Health Consortium would be excluded.

Where it's running

• Hospital de Terrassa
  Terrassa, Barcelona, Spain Recruiting

Study contacts

• Principal investigator: Anna Puigdellívol-Sánchez, Ph D — Consorci Sanitari de Terrassa
• Study coordinator: Anna Puigdellívol-Sánchez, Ph.D.
• Email: apuigdellivol@cst.cat
• Phone: 34-93-5884555

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Influenza Vaccine Immunogenicity in Older Adults with Repeated Vaccination

  This study tests how different flu vaccines perform in adults 65+ who get yearly vaccines to see if age and repeated vaccination affect the immune response.

  Recruiting Phase 4 Korea University Guro Hospital · Seoul · NCT07838298

• Amantadine or duloxetine added to pregabalin to prevent post-mastectomy pain

  This will see if adding amantadine or duloxetine to pregabalin around the time of modified radical mastectomy reduces the risk of long-term post-mastectomy pain in adults aged 18–65.

  Recruiting Cairo University · Cairo · NCT07421427

• Offering the nasal flu vaccine in daycare for young children

  This project will test whether offering the nasal (spray) influenza vaccine at daycare gets more children vaccinated than offering the vaccine only at healthcare clinics.

  Recruiting Turku University Hospital · Turku · NCT07310472

• OPGx-BEST1 subretinal gene therapy for Best vitelliform macular dystrophy and autosomal-recessive bestrophinopathy

  This trial will test whether a one-time subretinal gene therapy called OPGx-BEST1 is safe and can improve or stabilize vision in adults with Best vitelliform macular dystrophy (BVMD) or autosomal-recessive bestrophinopathy (ARB) in one eye.

  Recruiting at 4 sites Phase 1/2 Opus Genetics, Inc · Los Angeles, California and 4 other locations · NCT07185256

• Investigating olfactory dysfunction after COVID-19 infection

  This study is trying to understand why some people still have trouble smelling after recovering from COVID-19 by looking at samples from their noses.

  Recruiting at 6 sites Universitaire Ziekenhuizen KU Leuven · Brussels, Brussels Capital and 6 other locations · NCT06482138

• Registry to evaluate pregnancy outcomes in women treated for COVID-19

  This study is trying to see how treatments for COVID-19, like certain medications, affect the health of pregnant women and their babies.

  Recruiting Pregistry · Los Angeles, California · NCT05013632

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.